147 results
Page 2 of 8
8-K
EX-99.1
c1i8x8
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am
8-K
EX-99.1
vnfbpfqil1q5r
11 May 23
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
6:20am
PRE 14A
ela726axrtj 0vcwq1d8
21 Apr 23
Preliminary proxy
4:00pm
8-K
EX-99.1
4jy9ussj viel4zt75p9
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
EX-99.2
ot7ys5tpp qvne4dvf1p
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
EX-99.1
b10b v0talvqu7wjgo0
30 Nov 22
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
4:20pm
8-K
EX-99.1
2tr8540ykjx
10 Nov 22
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
6:27am
8-K
EX-99.1
lmidj7siosis9
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
EX-99.2
k422du7dr7ax4
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
EX-99.1
ot1fpdps ip
11 Aug 22
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update
6:31am
8-K
EX-99.1
iorvqvxj3uf r2qgl
12 May 22
Synlogic Reports First Quarter 2022 Financial Results and Provides Business Update
7:30am
8-K
EX-99.2
vli1vynf0e70g
17 Mar 22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:36am
8-K
EX-99.1
bq0fn7 a8u
17 Mar 22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:36am